Takeda shuffles pharma production
Japan's Takeda is to invest Y15.0 billion (€117m) in its plant at Hikari City, in anticipation of the closure of its Shonan facility in at the end of March 2006.
Japan's Takeda is to invest Y15.0 billion (€117m) in its plant at Hikari City, in anticipation of the closure of its Shonan facility in at the end of March 2006.
Porvair Sciences of the UK has launched MaxiLute, a new 48-well solid phase extraction (SPE) sample preparation microplate system.
BioProgress has started legal proceedings against Stanelco Fibre Optics claiming ownership of several patents related to processes used in gelatine-free encapsulation. Stanelco recently unveiled its own ambitions in this area after acquiring Adept...
The first grants have been awarded in the ENCODE program,an extension of the Human Genome Project which is hoping to develop an encyclopedia of function for all the sequences in the human genetic map. A $35m pilot project aimed at developing...
EaglePicher Pharmaceutical Services (EPPS) of the USA says it has received $1.8 million (€1.5m) in late-stage development contracts for active pharmaceutical ingredients (API).
Guava technologies has developed a new assay system for counting and viability testing of non-mammalian cells, including insect cells used in vaccine research.
Thermo Electron reports a rise in net income for the third quarter, after two consecutive quarters of contracting profits, although revenues declined.